(Q38863969)

7 September 2017

title

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy (English)

1 reference

7 September 2017

1 reference

6

Matthew L Albert

1 reference

7 September 2017

author name string

Rosa Barreira da Silva

1

1 reference

7 September 2017

Melissa E Laird

2

1 reference

7 September 2017

Nader Yatim

3

1 reference

7 September 2017

Laurence Fiette

4

1 reference

7 September 2017

Molly A Ingersoll

5

1 reference

7 September 2017

language of work or name

English

0 references

publication date

15 June 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

16

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

850-858

1 reference

Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells

7 September 2017

cites work

1 reference

Interstitial dendritic cell guidance by haptotactic chemokine gradients

21 January 2018

1 reference

Overview of the mechanisms regulating chemokine activity and availability.

21 January 2018

1 reference

Safety of dipeptidyl peptidase 4 inhibitors: a perspective review

21 January 2018

1 reference

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

21 January 2018

1 reference

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

21 January 2018

1 reference

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection

21 January 2018

1 reference

CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients

21 January 2018

1 reference

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

21 January 2018

1 reference

Prognostic and predictive impact of intra- and peritumoral immune infiltrates

21 January 2018

1 reference

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.

21 January 2018

1 reference

CXCR3 ligands: redundant, collaborative and antagonistic functions

21 January 2018

1 reference

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.

21 January 2018

1 reference

Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor

21 January 2018

1 reference

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3

21 January 2018

1 reference

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues

21 January 2018

1 reference

Structure and function in dipeptidyl peptidase IV and related proteins

21 January 2018

1 reference

Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker

21 January 2018

1 reference

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

21 January 2018

1 reference

In vivo processing of CXCL12α/SDF-1α after intravenous and subcutaneous administration to mice

21 January 2018

1 reference

Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip Arrays and SELDI-TOF-MS.

21 January 2018

1 reference

PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.

21 January 2018

1 reference

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

21 January 2018

1 reference

Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation.

21 January 2018

1 reference

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

In vivo regulation of chemokine activity by post-translational modification.

21 January 2018

1 reference

Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity

21 January 2018

1 reference

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Cellular constituents of immune escape within the tumor microenvironment

21 January 2018

1 reference

T cell receptor gene therapy for cancer

21 January 2018

1 reference

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

21 January 2018

1 reference

Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase

21 January 2018

1 reference

Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study

21 January 2018

1 reference

12 December 2020

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma

1 reference

12 December 2020

Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells

1 reference

12 December 2020

The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias

1 reference

12 December 2020

Modulation of hematopoietic stem cell homing and engraftment by CD26

1 reference

12 December 2020

Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis

1 reference

12 December 2020

Molecular characterization of dipeptidyl peptidase activity in serum

1 reference

12 December 2020

Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients

1 reference

12 December 2020

CpG still rocks! Update on an accidental drug

1 reference

12 December 2020

Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma

1 reference

12 December 2020

Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions

1 reference

12 December 2020

Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs

1 reference

12 December 2020

Identifiers

DOI

10.1038/NI.3201

1 reference

7 September 2017

1 reference